Table 4. Location of metastases in patients with spread to one (N = 7,990) or more (N = 6,975) sites.
| Site of metastasis | Total amount | As one of N listed metastases |
% multiple | Lung | Pleura/Mediastinum | Peritoneum | Liver | Other G-I | Urinary system | Skin | Nervous system | Bone | Adrenal | Ovary* | Other | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4+ | |||||||||||||||
| COLON | ||||||||||||||||||
| Lung | 2881 | 410 | 1406 | 718 | 347 | 86% | 100% | 5% | 15% | 73% | 7% | 1% | 1% | 8% | 11% | 3% | 2% | 11% |
| Pleura/Med. | 260 | 16 | 75 | 82 | 87 | 94% | 54% | 100% | 30% | 60% | 11% | 2% | 1% | 10% | 12% | 2% | 2% | 18% |
| Peritoneum | 2000 | 652 | 728 | 395 | 225 | 67% | 21% | 4% | 100% | 48% | 11% | 2% | 3% | 2% | 4% | 1% | 5% | 14% |
| Liver | 6587 | 3129 | 2200 | 873 | 385 | 52% | 32% | 2% | 14% | 100% | 7% | 1% | 1% | 3% | 6% | 1% | 1% | 8% |
| Other G-I | 909 | 230 | 317 | 221 | 141 | 75% | 23% | 3% | 24% | 50% | 100% | 5% | 3% | 2% | 5% | 1% | 3% | 16% |
| Urinary system | 217 | 72 | 67 | 42 | 36 | 67% | 19% | 2% | 18% | 32% | 19% | 100% | 3% | 4% | 5% | 4% | 1% | 19% |
| Skin | 168 | 40 | 47 | 38 | 43 | 76% | 25% | 2% | 30% | 42% | 15% | 4% | 100% | 5% | 11% | 1% | 2% | 23% |
| Nervous system | 429 | 90 | 104 | 134 | 99 | 79% | 54% | 6% | 7% | 53% | 5% | 2% | 2% | 100% | 17% | 6% | 1% | 10% |
| Bone | 717 | 145 | 203 | 203 | 166 | 80% | 45% | 4% | 10% | 59% | 7% | 1% | 3% | 10% | 100% | 4% | 2% | 16% |
| Adrenal | 139 | 8 | 43 | 43 | 45 | 94% | 55% | 4% | 12% | 65% | 6% | 6% | 1% | 17% | 19% | 100% | 1% | 14% |
| Ovary | 205 | 45 | 58 | 57 | 45 | 78% | 22% | 2% | 47% | 43% | 14% | 1% | 2% | 2% | 7% | 1% | 100% | 18% |
| Other | 1126 | 373 | 250 | 288 | 215 | 67% | 29% | 4% | 25% | 50% | 13% | 4% | 3% | 4% | 10% | 2% | 3% | 100% |
| RECTUM | ||||||||||||||||||
| Lung | 2591 | 550 | 1267 | 547 | 227 | 79% | 100% | 4% | 6% | 63% | 6% | 2% | 1% | 11% | 14% | 3% | 0% | 9% |
| Pleura/Med. | 156 | 11 | 43 | 55 | 47 | 93% | 74% | 100% | 10% | 58% | 4% | 4% | 3% | 13% | 18% | 3% | 0% | 15% |
| Peritoneum | 461 | 115 | 155 | 124 | 67 | 75% | 32% | 3% | 100% | 52% | 13% | 3% | 3% | 2% | 11% | 2% | 1% | 15% |
| Liver | 3898 | 1769 | 1354 | 556 | 219 | 55% | 42% | 2% | 6% | 100% | 6% | 1% | 1% | 5% | 10% | 2% | 0% | 7% |
| Other G-I | 377 | 57 | 141 | 119 | 60 | 85% | 38% | 2% | 15% | 58% | 100% | 5% | 2% | 5% | 13% | 3% | 1% | 12% |
| Urinary system | 115 | 13 | 28 | 45 | 29 | 89% | 42% | 5% | 13% | 43% | 16% | 100% | 3% | 11% | 19% | 8% | 2% | 31% |
| Skin | 83 | 16 | 20 | 26 | 21 | 81% | 46% | 5% | 16% | 40% | 10% | 5% | 100% | 11% | 22% | 7% | 1% | 18% |
| Nervous system | 442 | 75 | 129 | 142 | 98 | 83% | 65% | 5% | 2% | 46% | 4% | 3% | 2% | 100% | 18% | 7% | 0% | 13% |
| Bone | 681 | 118 | 194 | 227 | 142 | 83% | 54% | 4% | 7% | 57% | 7% | 3% | 3% | 11% | 100% | 5% | 0% | 13% |
| Adrenal | 108 | 8 | 19 | 28 | 53 | 93% | 70% | 5% | 8% | 58% | 9% | 8% | 6% | 30% | 31% | 100% | 0% | 15% |
| Ovary | 34 | 11 | 8 | 11 | 4 | 68% | 26% | 0% | 15% | 41% | 6% | 6% | 3% | 3% | 6% | 0% | 100% | 24% |
| Other | 602 | 37 | 293 | 168 | 104 | 94% | 40% | 4% | 11% | 43% | 8% | 6% | 2% | 9% | 14% | 3% | 1% | 100% |
Percentages indicate how many of all patients with site-specific metastases have multiple metastases also involving other sites.